MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/blood-2011-10-383711

Медицинская библиотека · Blood · 2012

Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet.

Guilhot Joëlle, Baccarani Michele, Clark Richard E, Cervantes Francisco, Guilhot François, Hochhaus Andreas, Kulikov Sergei, Mayer Jiri, Petzer Andreas L, Rosti Gianantonio, Rousselot Philippe, Saglio Giuseppe, Saussele Susanne, Simonsson Bengt, Steegmann Juan-Luis, Zaritskey Andrey, Hehlmann Rüdiger

Consensus StatementСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

The treatment policy of chronic myeloid leukemia (CML), particularly with tyrosine kinase inhibitors, has been influenced by several recent studies that were well designed and rapidly performed, but their interpretation is of some concern because different end points and methodologies were used. To understand and compare the results of the previous and future studies and to translate their conclusion into clinical practice, there is a need for common definitions and methods for analyses of CML studies. A panel of experts was appointed by the European LeukemiaNet with the aim of developing a set of definitions and recommendations to be used in design, analyses, and reporting of phase 3 clinical trials in this disease. This paper summarizes the consensus of the panel on events and major end points of interest in CML. It also focuses on specific issues concerning the intention-to-treat principle and longitudinal data analyses in the context of long-term follow-up. The panel proposes that future clinical trials follow these recommendations.

Для цитирования: Guilhot Joëlle, Baccarani Michele, Clark Richard E, Cervantes Francisco, Guilhot François, Hochhaus Andreas, Kulikov Sergei, Mayer Jiri, Petzer Andreas L, Rosti Gianantonio, Rousselot Philippe, Saglio Giuseppe, Saussele Susanne, Simonsson Bengt, Steegmann Juan-Luis, Zaritskey Andrey, Hehlmann Rüdiger. Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet.. Blood. 2012. DOI: 10.1182/blood-2011-10-383711.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.